EIC Accelerator Challenges 2021- Strategic Digital and Health Technologies

Closed

Programme Category

EU Competitive Programmes

Programme Name

Horizon Europe (2021-2027)

Programme Description

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Details

Identifier Code

HORIZON-EIC-2021-ACCELERATORCHALLENGES-01  

Call

EIC Accelerator Challenges 2021- Strategic Digital and Health Technologies

Summary

With this EIC Accelerator challenge, the European Innovation Council (EIC) seeks to support start- ups and SMEs (including small midcaps) that are developing strategic technologies or innovations based on these technologies, in order to be ahead of the evolution of these technologies, capture the competitive advantages and scale up high impact innovations with the potential to create new markets or disrupt existing ones in identified areas of Strategic Digital and Health Technologies.

Detailed Call Description

apply to the EIC Accelerator Challenge – Strategic Digital and Health Technologies, if they believe that their company, has the potential to be a global leader in developing strategic technologies in one of the following areas:

  • Digital technologies: devices, methods, systems as well as working principles, processes and standards which apply to the ICT technology industry such as advanced high- performance computing, edge computing, quantum technologies, cybersecurity, artificial intelligence, block-chain, cloud infrastructure technologies and technologies for the Internet of Things.
  • Healthcare technologies: AI-driven tools for early diagnosis, point-of-care diagnostics novel approaches in cell and gene therapy, in particular for cancer, development of novel biomarkers for clinical prognosis, patient stratification or monitoring purposes across a wide spectrum of disorders, bioprocessing 4.0 (digitalisation across stages of biodevelopment in biotech/biopharma industry), healthcare intelligence services, and e- health (including mobile health) solutions for healthcare systems, medical practice and Intensive Care Units.

The proposals must clearly describe the contribution of each project towards increasing Europe’s leadership in one or more of the above mentioned strategic technologies and also be based on a strategic business plan. Furthermore, the activities supported could include, product/service development, trials, optimisation, prototyping, validation, demonstration and testing in real world conditions and market replication.

Call Total Budget

€496,760,000  

Financing percentage by EU or other bodies / Level of Subsidy or Loan

For a grant component the eligible costs are reimbursed up to a maximum of 70%.

Thematic Categories

  • Health
  • Information Technology
  • Research, Technological Development and Innovation
  • Small-Medium Enterprises and Competitiveness

Eligibility for Participation

  • Researchers/Research Centers/Institutions
  • Small and Medium Enterprises (SMEs)

Eligibility For Participation Notes

For an applicant to be able to apply, they must meet one of the following eligibility conditions:

  • A single company classified as an SME and established within a Member State or an Associated Country.
  •  A single company classified as a ‘Small mid-cap’ (up to 500 employees) established in a Member State or an Associated Country, but the application can only be for rapid scale up purposes and only for the investment component.
  • One or more natural persons (including individual entrepreneurs) or legal entities, intending to establish an SME or small mid-cap, intending to invest in an SME or small mid- cap, from a non-associated third country intending to establish an SME (including start-ups) or to relocate an existing SME to a Member State or an Associated Country, by the time of submitting a full application. Τhe company must prove its effective establishment in a Member State or an Associated Country.

Call Opening Date

08/04/2021

Call Closing Date

06/10/2021

National Contact Point(s)

Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.O.Box 23422, 1683 Nicosia
Phone Number: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/

Contact Persons:
Ms Katerina Karakasidou
Scientific Officer
Contact Phone: +357 22 205 036
Contact Email: kkarakasidou@research.org.cy

Dr Kalypso Sepou
Head of European Programmes Department
Contact Phone: +357 22 205066
Contact Email: kalypso@research.org.cy

EU Contact Point

European Innovation Council: https://eic.ec.europa.eu/contact-form_en